Heather Lyon

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Diabetic Retinopathy

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Odunayo Omolola Mugisho, Jyoti Aryal, Avik Shorne, Heather Lyon, Monica L Acosta, Colin R Green, Ilva Dana Rupenthal
Orally Delivered Connexin43 Hemichannel Blocker, Tonabersat, Inhibits Vascular Breakdown and Inflammasome Activation in a Mouse Model of Diabetic Retinopathy. International journal of molecular sciences 24 (4) (2023)
Odunayo Omolola Mugisho, Jyoti Aryal, Avik Shorne, Heather Lyon, Monica L Acosta, Colin R Green, Ilva Dana Rupenthal
Orally Delivered Connexin43 Hemichannel Blocker, Tonabersat, Inhibits Vascular Breakdown and Inflammasome Activation in a Mouse Model of Diabetic Retinopathy. International journal of molecular sciences 24 (4) (2023)
Odunayo Omolola Mugisho, Jyoti Aryal, Avik Shorne, Heather Lyon, Monica L Acosta, Colin R Green, Ilva Dana Rupenthal
Orally Delivered Connexin43 Hemichannel Blocker, Tonabersat, Inhibits Vascular Breakdown and Inflammasome Activation in a Mouse Model of Diabetic Retinopathy. International journal of molecular sciences 24 (4) (2023)
Odunayo Omolola Mugisho, Jyoti Aryal, Avik Shorne, Heather Lyon, Monica L Acosta, Colin R Green, Ilva Dana Rupenthal
Orally Delivered Connexin43 Hemichannel Blocker, Tonabersat, Inhibits Vascular Breakdown and Inflammasome Activation in a Mouse Model of Diabetic Retinopathy. International journal of molecular sciences 24 (4) (2023)
Odunayo Omolola Mugisho, Jyoti Aryal, Avik Shorne, Heather Lyon, Monica L Acosta, Colin R Green, Ilva Dana Rupenthal
Orally Delivered Connexin43 Hemichannel Blocker, Tonabersat, Inhibits Vascular Breakdown and Inflammasome Activation in a Mouse Model of Diabetic Retinopathy. International journal of molecular sciences 24 (4) (2023)
Odunayo Omolola Mugisho, Jyoti Aryal, Avik Shorne, Heather Lyon, Monica L Acosta, Colin R Green, Ilva Dana Rupenthal
Orally Delivered Connexin43 Hemichannel Blocker, Tonabersat, Inhibits Vascular Breakdown and Inflammasome Activation in a Mouse Model of Diabetic Retinopathy. International journal of molecular sciences 24 (4) (2023)
Heather Lyon, Avik Shome, Ilva Dana Rupenthal, Colin R Green, Odunayo O Mugisho
Tonabersat Inhibits Connexin43 Hemichannel Opening and Inflammasome Activation in an In Vitro Retinal Epithelial Cell Model of Diabetic Retinopathy. International journal of molecular sciences 22 (1) (2020)